Home/Pipeline/VeraPoint qPCR Assay Portfolio Expansion

VeraPoint qPCR Assay Portfolio Expansion

Various Infectious Diseases (Respiratory, UTI, STI, GI, Wound, Bloodborne, AMR)

CommercialActive

Key Facts

Indication
Various Infectious Diseases (Respiratory, UTI, STI, GI, Wound, Bloodborne, AMR)
Phase
Commercial
Status
Active
Company

About Lusis

Lusis Biosciences is a private, commercial-stage diagnostics company developing and manufacturing multiplex qPCR assays and instruments for infectious disease applications. The company leverages integrated development and manufacturing to offer a broad catalog of over 30 key products and hundreds of targets, which are used by over 10,000 laboratories across 160 countries. Its business model centers on providing affordable, high-performance molecular tools paired with dedicated customer support and field application services. Lusis operates under the philosophy of 'Innovation for All,' aiming to improve healthcare equity through accessible diagnostic solutions.

View full company profile

Therapeutic Areas